ArticleDiabetes, obesity & metabolism2023

Cardiovascular and kidney outcomes with canagliflozin according to type 2 diabetes treatment targets at baseline: Data from the CANVAS programme and CREDENCE.

Michael A Tsoukas et al.PubMed ↗Publisher ↗

No numbers read from the abstract.